Subscribe

Indraprastha Medical Corporation Limited (INDRAMEDCO.NS)

INR375.90 +2.00 (+0.53%)
IN NSE Healthcare Medical - Care Facilities
Address Sarita Vihar 110076
New Delhi, IN
CEO Shivakumar Pattabhiraman
Website delhi.apollohospitals.com
IPO 1997-05-07
ISIN INE681B01017

Explore sections of this company profile

Also trades on Bombay Stock Exchange · INDRAMEDCO.BO (INR) National Stock Exchange of India · INDRAMEDCO.NS (INR)
Description

Indraprastha Medical Corporation Limited (IMCL) is a prominent Indian healthcare provider, delivering a broad spectrum of hospital services across the nation. The company offers comprehensive medical and surgical solutions across an extensive range of specialties. Its offerings encompass areas like anesthesiology, pediatrics, elder care, genomic medicine, preventative health checks, and a variety of complex surgical interventions, including bariatric, metabolic, bone marrow, cardiac, endovascular, laparoscopic, robotic, spine, pediatric urology, pediatric surgery, transplant, and urology and andrology. Furthermore, IMCL provides specialized medical departments for cancer, cardiology, dermatology, dietetics and clinical nutrition, emergency care, endocrinology/diabetes, ENT, fetal medicine, gastroenterology and hepatology, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedics, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, and transfusion medicine. In addition to its core hospital services, IMCL also operates dedicated cosmetic and dental clinics. Established in 1988, the corporation is headquartered in New Delhi, India.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR375.90 +2.00 (+0.53%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
344.7K
Beta
0.42
Float Shares
40.98M
Free Float %
44.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+2.04% -1.41% -2.50% +0.42% -18.34% -14.19% -5.84% +333.00% +320.68% +618.02% +4,102.19%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
375.90
DCF (Unlevered) 920.21 +144.8%
DCF (Levered) 695.27 +85.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-06 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
10.87
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +9.3% Q1'26: +9.3% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +14.1% Q1'26: +1.8% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +8.4% Q1'26: +22.2% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +15.1% ★ Q1'26: +13.5% (vs Q1'25)
  • ✓
    ROIC Medical - Care Facilities: +6.8%
    +33.1% ★ Q1'26: +29.0% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    0.0% ★ Q1'26: -0.1% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.14× ★ Q1'26: 0.15× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.42) × ERP
WACC = 99% × Ke + 1% × Kd (16.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 911.88 Current price: 375.90
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2014
actual 		Mar 2015
actual 		Mar 2016
actual 		Mar 2017
actual 		Mar 2018
actual 		Mar 2019
actual 		Mar 2020
actual 		Mar 2021
actual 		Mar 2022
actual 		Mar 2023
actual 		Mar 2024
actual 		Mar 2025
actual 		Mar 2026
1 Rev. Ana.
1 EPS Ana. 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana. 		Mar 2029
1 Rev. Ana.
1 EPS Ana. 		Mar 2030
1 Rev. Ana.
1 EPS Ana. 		Mar 2031
1 Rev. Ana.
1 EPS Ana. 		Mar 2032
1 Rev. Ana.
1 EPS Ana.
Revenue
6.60B
est: 6.97B (-5.3%)
6.93B
est: 7.16B (-3.2%)
7.33B
est: 7.64B (-4.1%)
7.29B
est: 7.71B (-5.4%)
7.20B
est: 7.64B (-5.7%)
7.60B
est: 7.71B (-1.4%)
7.97B
est: 7.48B (+6.5%)
6.13B
est: 7.64B (-19.7%)
8.88B
est: 8.45B (+5.1%)
10.99B
est: 8.97B (+22.5%)
12.45B
est: 9.87B (+26.1%)
13.56B
est: 13.48B (+0.6%)
14.76B
14.76B – 14.76B
+9.5% YoY
15.77B
15.77B – 15.77B
+6.8% YoY
16.88B
16.88B – 16.88B
+7.1% YoY
8.45B
8.45B – 8.45B
-49.9% YoY
8.97B
8.97B – 8.97B
+6.2% YoY
9.87B
9.87B – 9.87B
+10.0% YoY
9.87B
9.87B – 9.87B
+0.0% YoY
EBITDA
918.48M
est: 964.30M (-4.8%)
858.30M
est: 785.34M (+9.3%)
814.96M
est: 774.71M (+5.2%)
792.55M
est: 1.07B (-25.7%)
721.99M
est: 1.06B (-31.7%)
773.76M
est: 1.07B (-27.4%)
822.92M
est: 1.04B (-20.5%)
409.48M
est: 927.96M (-55.9%)
1.17B
est: 1.17B (+0.4%)
1.61B
est: 950.11M (+69.2%)
2.07B
est: 2.90B (-28.6%)
2.44B
est: 3.24B (-24.7%)
3.55B
3.55B – 3.55B
+9.5% YoY
3.80B
3.80B – 3.80B
+6.8% YoY
4.06B
4.06B – 4.06B
+7.1% YoY
2.03B
2.03B – 2.03B
-49.9% YoY
2.16B
2.16B – 2.16B
+6.2% YoY
2.38B
2.38B – 2.38B
+10.0% YoY
2.38B
2.38B – 2.38B
+0.0% YoY
EBIT
637.05M
est: 693.50M (-8.1%)
548.48M
est: 655.98M (-16.4%)
431.58M
est: 604.48M (-28.6%)
455.00M
est: 766.94M (-40.7%)
395.90M
est: 759.78M (-47.9%)
476.22M
est: 766.94M (-37.9%)
493.23M
est: 744.75M (-33.8%)
76.25M
est: 669.08M (-88.6%)
824.80M
est: 840.78M (-1.9%)
1.21B
est: 687.37M (+76.7%)
1.67B
est: 2.77B (-39.7%)
2.00B
est: 2.98B (-33.0%)
3.27B
3.27B – 3.27B
+9.5% YoY
3.49B
3.49B – 3.49B
+6.8% YoY
3.74B
3.74B – 3.74B
+7.1% YoY
1.87B
1.87B – 1.87B
-49.9% YoY
1.99B
1.99B – 1.99B
+6.2% YoY
2.18B
2.18B – 2.18B
+10.0% YoY
2.18B
2.18B – 2.18B
+0.0% YoY
Net Income
354.36M
est: 369.38M (-4.1%)
324.91M
est: 369.72M (-12.1%)
282.34M
est: 346.34M (-18.5%)
262.45M
est: 238.37M (+10.1%)
211.03M
est: 403.39M (-47.7%)
284.13M
est: 238.37M (+19.2%)
436.24M
est: 192.53M (+126.6%)
23.30M
est: 229.20M (-89.8%)
586.20M
est: 477.65M (+22.7%)
861.50M
est: 550.84M (+56.4%)
1.24B
est: 530.83M (+133.5%)
1.61B
est: 1.61B (-0.2%)
1.89B
1.89B – 1.89B
+17.0% YoY
2.07B
2.07B – 2.07B
+9.7% YoY
2.26B
2.26B – 2.26B
+8.8% YoY
477.61M
477.61M – 477.61M
-78.8% YoY
478.53M
478.53M – 478.53M
+0.2% YoY
530.78M
530.78M – 530.78M
+10.9% YoY
530.78M
530.78M – 530.78M
+0.0% YoY
SGA
414.26M
est: 510.33M (-18.8%)
437.26M
est: 2.46B (-82.3%)
470.93M
est: 2.85B (-83.5%)
477.38M
est: 564.38M (-15.4%)
476.23M
est: 559.11M (-14.8%)
499.73M
est: 564.38M (-11.5%)
569.19M
est: 548.05M (+3.9%)
320.87M
est: 3.90B (-91.8%)
602.10M
est: 4.29B (-86.0%)
969.60M
est: 4.64B (-79.1%)
1.16B
est: 722.74M (+60.5%)
876.50M
est: 1.36B (-35.5%)
1.49B
1.49B – 1.49B
+9.5% YoY
1.59B
1.59B – 1.59B
+6.8% YoY
1.70B
1.70B – 1.70B
+7.1% YoY
852.05M
852.05M – 852.05M
-49.9% YoY
904.82M
904.82M – 904.82M
+6.2% YoY
995.30M
995.30M – 995.30M
+10.0% YoY
995.30M
995.30M – 995.30M
+0.0% YoY
EPS
3.87
est: 4.03 (-3.9%)
3.54
est: 3.68 (-3.9%)
2.67
est: 4.40 (-39.3%)
2.86
est: 2.60 (+10.0%)
2.30
est: 4.40 (-47.7%)
3.10
est: 2.60 (+19.2%)
4.76
est: 2.10 (+126.7%)
0.25
est: 2.50 (-90.0%)
6.39
est: 5.21 (+22.6%)
9.40
est: 5.22 (+80.1%)
13.52
est: 5.79 (+133.5%)
17.56
est: 17.60 (-0.2%)
20.60
20.60 – 20.60
+17.0% YoY
22.60
22.60 – 22.60
+9.7% YoY
24.60
24.60 – 24.60
+8.8% YoY
5.21
5.21 – 5.21
-78.8% YoY
5.22
5.22 – 5.22
+0.2% YoY
5.79
5.79 – 5.79
+10.9% YoY
5.79
5.79 – 5.79
+0.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-06-12 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-06-11 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-06-10 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-06-09 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-06-08 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-06-05 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-06-04 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-06-03 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-06-02 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-06-01 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-29 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-27 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-26 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-25 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-22 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-21 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-20 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-19 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-18 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-15 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-14 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-13 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-12 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-11 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-08 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-07 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-06 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-05 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-05-04 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-30 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-29 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-28 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-27 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-24 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-23 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-22 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-21 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-20 C 2/5 4/5 1/5 1/5 1/5 3/5 1/5
2026-04-17 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-04-16 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
308.26M
OE per share TTM
3.36
Owner's Yield
0.87%
Maintenance CapEx ratio
9.89%
Maint CapEx / Avg PPE
29.6%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
750.1K
Shares Outstanding
91.67M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Shivakumar MD & Additional Director 29M male
Chander Prakash Tyagi Chief Financial Officer — male
Priya Ranjan Company Secretary & Compliance Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities